MRK
Merck & Co Inc
$148.70
0.80 (0.54%) Today
0.04 (0.03%) After-hours
— up— down
Market Cap
$367.07B+89.4%
Revenue (TTM)
$66.56B+4.6%
Net Income (TTM)
$3.09B-80.7%
EPS (TTM)
1.25-80.7%
Shares Out
2.47B
2.47BP/E Ratio
115.68
115.68Forward P/E
19.63
19.63Dividend
$3.27 (2.87%)
$3.27 (2.87%)Ex-Dividend Date
Sep 15, 2026
Sep 15, 2026Open
$148.78
$148.78Previous Close
$147.98
$147.98Day Range
$147.48 – $149.94
$147.48 – $149.9452-Week Range
$78.03 – $156.92
$78.03 – $156.92Beta
0.14
0.14Volume
8.26M
8.26MAvg Volume
10.58M
10.58MAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About MRK
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
Related
News
N/AN/A
N/AN/A
Merck Is Up 40% This Year, but Is the Keytruda Rebuild Already Priced In?
Yahoo · 1d ago
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval
Yahoo · 2d ago
Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years
Benzinga · 2d ago
Merck, Daiichi Sankyo Voluntarily Withdraw Biologics License Application Approval In U.S. For Ifinatamab Deruxtecan To Treat Small Cell Lung Cancer After Discussions With FDA
Benzinga · 2d ago
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
Yahoo · 2d ago